Prescribing intelligence for ADHD therapies

Prescriptions for CNS stimulants to treat ADHD are increasing. In England there was a 9% growth in patient numbers mid-2017 to mid-2018, with over a million prescription items issued, predominantly to males aged 7-18.

Medications are grouped into 12 hour or 8 hour modified release methylphenidate, immediate release methylphenidate, Lisdexamfetamine, Atomoxetine and Guafacine.

The RxIndex to the right monitors the performance of all modified release methylphenidate brands, the most frequently prescribed drugs for ADHD.


GPrX Data Ltd

Additional resources relating to ADHD prescribing

Additional resources coming soon!

Ready to start the conversation?

Our friendly team loves talking data. Schedule a chat or an online demo now!